US 10,350,272 B2Granted

Calcitonin analogues for treating diseases and disorders

AssigneeKeyBioscience AG

InventorsMorten Karsdal, Kim Henriksen, Kim Vietz Andreassen, Sofie Gydesen, Sara Toftegaard Hjuler

Life of this patent

Estimating the term…

Abstract

Calcitonin analogues as a medicament for producing a decrease in liver triglycerides or for reducing fat accumulation in the liver of a subject are provided.

Claims5

Dependent claims

A method of producing a decrease in liver triglycerides or reducing fat accumulation or a combination thereof in the liver of a subject mammal in need thereof which comprises administering an effective amount of a calcitonin analogue comprising a sequence shown in SEQ ID NO:

Dependencies are inferred from the claim text.

Facts

Application: 15/542,191Filed 7 Jan 2016
Priority: GB 1500263.78 Jan 2015
Published: US 2018/0264085 A120 Sep 2018
Granted: 16 Jul 2019
Term ends: Not estimatedThe source records don’t support an estimate.

Classification5 codes

A61K 38/23
Hormones: calcitonins
A61P 1/16
Drugs for disorders of the alimentary tract or the digestive system: for liver or gallbladder disorders, e.g. hepatoprotective agents,…
A61P 3/06
Drugs for disorders of the metabolism: antihyperlipidemics
A61K
Medicines and medical preparations

Family

US 2018/0264085 A1Pre-grant publication · published 20 Sep 2018
US 10,350,272 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results